Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation

Lucas Sagrillo-Fagundes, Eugênia M. Assunção Salustiano, Rodrigo Ruano, Regina P. Markus, Cathy Vaillancourt

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Melatonin has been proposed as a possible treatment for the deleterious effects of hypoxia/reoxygenation (H/R), such as autophagy, inflammation, and apoptosis. Pathological pregnancies, such as preeclampsia, are associated with placental H/R, and decreased placental melatonin synthesis as well as lower melatonin levels in the placenta and maternal plasma. However, the effects of exogenous melatonin on inflammation and autophagy induced by pregnancy complications associated with H/R await investigation. This study aimed to determine as to whether melatonin protects human primary villous trophoblasts against H/R-induced autophagy, inflammation, and apoptosis. Human primary villous cytotrophoblasts were isolated and immunopurified from normal term placentas. These cells were then exposed or not to 1 mmol/L melatonin for 72 hour in normoxia (8% O2), thereby inducing differentiation into syncytiotrophoblast that was then exposed to H/R (0.5% O2, for 4 hour) or normoxia. H/R decreased endogenous melatonin synthesis (by 68%) and interleukin (IL)-10 levels (by 72%), coupled to increased tumor necrosis factor (TNF) (by 114%), IL-6 (by 55%), and NFκB (by 399%), compared to normoxia. Melatonin treatment reversed the H/R effect, restoring IL-10, TNF, and IL-6 levels to those of the normoxia condition. Melatonin, as well as NFκB inhibition, enhanced autophagy activation, consequently increasing syncytiotrophoblast survival in H/R conditions. This study suggests that H/R, which is present in pregnancy complications, inhibits endogenous melatonin production, thereby contributing to reduced syncytiotrophoblast viability. Results indicate that exogenous melatonin treatment may afford protection against H/R-induced damage, thereby enhancing placental cell survival, and contributing to improved fetal outcomes.

Original languageEnglish (US)
JournalJournal of Pineal Research
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Autophagy
Trophoblasts
Melatonin
Inflammation
Pregnancy Complications
Interleukin-10
Placenta
Interleukin-6
Hypoxia
Tumor Necrosis Factor-alpha
Apoptosis
Pre-Eclampsia
Cell Survival
Mothers
Pregnancy

Keywords

  • arylalkylamine N-acetyltransferase (AANAT)
  • IL-10
  • interleukin (IL)-6
  • NFκB
  • pregnancy
  • syncytiotrophoblast
  • TNF
  • villous cytotrophoblasts

ASJC Scopus subject areas

  • Endocrinology

Cite this

Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation. / Sagrillo-Fagundes, Lucas; Assunção Salustiano, Eugênia M.; Ruano, Rodrigo; Markus, Regina P.; Vaillancourt, Cathy.

In: Journal of Pineal Research, 01.01.2018.

Research output: Contribution to journalArticle

Sagrillo-Fagundes, Lucas ; Assunção Salustiano, Eugênia M. ; Ruano, Rodrigo ; Markus, Regina P. ; Vaillancourt, Cathy. / Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation. In: Journal of Pineal Research. 2018.
@article{bbf6dcd5562c4473bd6c7cc31d5d69c2,
title = "Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation",
abstract = "Melatonin has been proposed as a possible treatment for the deleterious effects of hypoxia/reoxygenation (H/R), such as autophagy, inflammation, and apoptosis. Pathological pregnancies, such as preeclampsia, are associated with placental H/R, and decreased placental melatonin synthesis as well as lower melatonin levels in the placenta and maternal plasma. However, the effects of exogenous melatonin on inflammation and autophagy induced by pregnancy complications associated with H/R await investigation. This study aimed to determine as to whether melatonin protects human primary villous trophoblasts against H/R-induced autophagy, inflammation, and apoptosis. Human primary villous cytotrophoblasts were isolated and immunopurified from normal term placentas. These cells were then exposed or not to 1 mmol/L melatonin for 72 hour in normoxia (8{\%} O2), thereby inducing differentiation into syncytiotrophoblast that was then exposed to H/R (0.5{\%} O2, for 4 hour) or normoxia. H/R decreased endogenous melatonin synthesis (by 68{\%}) and interleukin (IL)-10 levels (by 72{\%}), coupled to increased tumor necrosis factor (TNF) (by 114{\%}), IL-6 (by 55{\%}), and NFκB (by 399{\%}), compared to normoxia. Melatonin treatment reversed the H/R effect, restoring IL-10, TNF, and IL-6 levels to those of the normoxia condition. Melatonin, as well as NFκB inhibition, enhanced autophagy activation, consequently increasing syncytiotrophoblast survival in H/R conditions. This study suggests that H/R, which is present in pregnancy complications, inhibits endogenous melatonin production, thereby contributing to reduced syncytiotrophoblast viability. Results indicate that exogenous melatonin treatment may afford protection against H/R-induced damage, thereby enhancing placental cell survival, and contributing to improved fetal outcomes.",
keywords = "arylalkylamine N-acetyltransferase (AANAT), IL-10, interleukin (IL)-6, NFκB, pregnancy, syncytiotrophoblast, TNF, villous cytotrophoblasts",
author = "Lucas Sagrillo-Fagundes and {Assun{\cc}{\~a}o Salustiano}, {Eug{\^e}nia M.} and Rodrigo Ruano and Markus, {Regina P.} and Cathy Vaillancourt",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/jpi.12520",
language = "English (US)",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation

AU - Sagrillo-Fagundes, Lucas

AU - Assunção Salustiano, Eugênia M.

AU - Ruano, Rodrigo

AU - Markus, Regina P.

AU - Vaillancourt, Cathy

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Melatonin has been proposed as a possible treatment for the deleterious effects of hypoxia/reoxygenation (H/R), such as autophagy, inflammation, and apoptosis. Pathological pregnancies, such as preeclampsia, are associated with placental H/R, and decreased placental melatonin synthesis as well as lower melatonin levels in the placenta and maternal plasma. However, the effects of exogenous melatonin on inflammation and autophagy induced by pregnancy complications associated with H/R await investigation. This study aimed to determine as to whether melatonin protects human primary villous trophoblasts against H/R-induced autophagy, inflammation, and apoptosis. Human primary villous cytotrophoblasts were isolated and immunopurified from normal term placentas. These cells were then exposed or not to 1 mmol/L melatonin for 72 hour in normoxia (8% O2), thereby inducing differentiation into syncytiotrophoblast that was then exposed to H/R (0.5% O2, for 4 hour) or normoxia. H/R decreased endogenous melatonin synthesis (by 68%) and interleukin (IL)-10 levels (by 72%), coupled to increased tumor necrosis factor (TNF) (by 114%), IL-6 (by 55%), and NFκB (by 399%), compared to normoxia. Melatonin treatment reversed the H/R effect, restoring IL-10, TNF, and IL-6 levels to those of the normoxia condition. Melatonin, as well as NFκB inhibition, enhanced autophagy activation, consequently increasing syncytiotrophoblast survival in H/R conditions. This study suggests that H/R, which is present in pregnancy complications, inhibits endogenous melatonin production, thereby contributing to reduced syncytiotrophoblast viability. Results indicate that exogenous melatonin treatment may afford protection against H/R-induced damage, thereby enhancing placental cell survival, and contributing to improved fetal outcomes.

AB - Melatonin has been proposed as a possible treatment for the deleterious effects of hypoxia/reoxygenation (H/R), such as autophagy, inflammation, and apoptosis. Pathological pregnancies, such as preeclampsia, are associated with placental H/R, and decreased placental melatonin synthesis as well as lower melatonin levels in the placenta and maternal plasma. However, the effects of exogenous melatonin on inflammation and autophagy induced by pregnancy complications associated with H/R await investigation. This study aimed to determine as to whether melatonin protects human primary villous trophoblasts against H/R-induced autophagy, inflammation, and apoptosis. Human primary villous cytotrophoblasts were isolated and immunopurified from normal term placentas. These cells were then exposed or not to 1 mmol/L melatonin for 72 hour in normoxia (8% O2), thereby inducing differentiation into syncytiotrophoblast that was then exposed to H/R (0.5% O2, for 4 hour) or normoxia. H/R decreased endogenous melatonin synthesis (by 68%) and interleukin (IL)-10 levels (by 72%), coupled to increased tumor necrosis factor (TNF) (by 114%), IL-6 (by 55%), and NFκB (by 399%), compared to normoxia. Melatonin treatment reversed the H/R effect, restoring IL-10, TNF, and IL-6 levels to those of the normoxia condition. Melatonin, as well as NFκB inhibition, enhanced autophagy activation, consequently increasing syncytiotrophoblast survival in H/R conditions. This study suggests that H/R, which is present in pregnancy complications, inhibits endogenous melatonin production, thereby contributing to reduced syncytiotrophoblast viability. Results indicate that exogenous melatonin treatment may afford protection against H/R-induced damage, thereby enhancing placental cell survival, and contributing to improved fetal outcomes.

KW - arylalkylamine N-acetyltransferase (AANAT)

KW - IL-10

KW - interleukin (IL)-6

KW - NFκB

KW - pregnancy

KW - syncytiotrophoblast

KW - TNF

KW - villous cytotrophoblasts

UR - http://www.scopus.com/inward/record.url?scp=85052857348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052857348&partnerID=8YFLogxK

U2 - 10.1111/jpi.12520

DO - 10.1111/jpi.12520

M3 - Article

C2 - 30091210

AN - SCOPUS:85052857348

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

ER -